Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2021 16:20 ET | Source: Generation Bio Co.

Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results

CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
August 03, 2021 07:30 ET | Source: Generation Bio Co.

Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021

CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
July 14, 2021 07:30 ET | Source: Generation Bio Co.

Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update

Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing Lease agreement signed to build an...
July 08, 2021 07:30 ET | Source: Generation Bio Co.

Generation Bio to Present at William Blair Biotech Focus Conference

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
June 09, 2021 07:30 ET | Source: Generation Bio Co.

Generation Bio to Present at the JMP Securities Life Sciences Conference

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
May 27, 2021 07:30 ET | Source: Generation Bio Co.

Generation Bio to Present at the Jefferies Virtual Healthcare Conference

CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
May 12, 2021 16:20 ET | Source: Generation Bio Co.

Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results

Durable, therapeutically relevant levels of anti-SARS-CoV-2 spike antibodies produced from the liver in a mouse model Next-generation rapid enzymatic synthesis of closed-ended DNA further increases...
April 27, 2021 16:35 ET | Source: Generation Bio Co.

Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting

CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced three...
April 08, 2021 07:30 ET | Source: Generation Bio Co.

Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference

CAMBRIDGE, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
March 18, 2021 08:00 ET | Source: Generation Bio Co.

Generation Bio Reports Fourth Quarter and Full Year 2020 Financial Results

$262.3 million cash balance at the end of 2020 bolstered by additional net proceeds of $211.3 million from follow-on offering, funding key milestones into 2024 Ron Cooper appointed to Board of...